Cholera vaccine: new preventive tool for endemic countries

Area of Science:

• Public Health
• Infectious Diseases
• Epidemiology

Background:

• Cholera is a severe diarrheal disease caused by Vibrio cholerae, posing a major global health challenge, especially in regions with poor sanitation and overcrowding.
• Untreated cholera has a high mortality rate (30-50%), with millions of estimated cases and over 100,000 deaths annually worldwide.
• Outbreaks frequently occur after natural disasters or in displaced populations due to inadequate water and sewage infrastructure.

Purpose of the Study:

• To review the global and regional burden of cholera, focusing on endemic areas and outbreak patterns.
• To evaluate the effectiveness and applicability of a newly developed, affordable cholera vaccine.

Main Methods:

• Analysis of reported cholera cases and deaths from global health organizations (e.g., WHO).
• Review of epidemiological data on cholera outbreaks in specific regions, including India.
• Assessment of a novel killed whole-cell cholera vaccine developed in Vietnam.

Main Results:

• Cholera is endemic in parts of Africa, Asia, the Middle East, and South America, with significant underreporting of actual cases and deaths.
• India experiences numerous outbreaks, particularly in specific states, with a reported case fatality rate below 1%.
• A new Vietnamese vaccine provides 50% protection for at least three years against Vibrio cholerae O1 and O139.

Conclusions:

• Cholera control is feasible in endemic areas with high population immunity through targeted vaccination strategies.
• The new, affordable vaccine is recommended for use in endemic regions and outbreak-prone areas, alongside other preventive measures.
• Integrated strategies, including vaccination and improved sanitation, are crucial for managing the global burden of cholera.